131 related articles for article (PubMed ID: 1283532)
21. Excitotoxicity in the lung: N-methyl-D-aspartate-induced, nitric oxide-dependent, pulmonary edema is attenuated by vasoactive intestinal peptide and by inhibitors of poly(ADP-ribose) polymerase.
Said SI; Berisha HI; Pakbaz H
Proc Natl Acad Sci U S A; 1996 May; 93(10):4688-92. PubMed ID: 8643465
[TBL] [Abstract][Full Text] [Related]
22. N(omega)-nitro-L-arginine methyl ester protects retinal neurons against N-methyl-D-aspartate-induced neurotoxicity in vivo.
Morizane C; Adachi K; Furutani I; Fujita Y; Akaike A; Kashii S; Honda Y
Eur J Pharmacol; 1997 Jun; 328(1):45-9. PubMed ID: 9203567
[TBL] [Abstract][Full Text] [Related]
23. Involvement of nitric oxide in long-term potentiation in the dentate gyrus in vivo.
Mizutani A; Saito H; Abe K
Brain Res; 1993 Mar; 605(2):309-11. PubMed ID: 7683237
[TBL] [Abstract][Full Text] [Related]
24. A dual role for nitric oxide in NMDA-mediated toxicity in vivo.
Globus MY; Prado R; Sanchez-Ramos J; Zhao W; Dietrich WD; Busto R; Ginsberg MD
J Cereb Blood Flow Metab; 1995 Nov; 15(6):904-13. PubMed ID: 7593350
[TBL] [Abstract][Full Text] [Related]
25. Effect of nitric oxide synthase inhibition on long-term potentiation at associational-commissural and mossy fibre synapses on CA3 pyramidal neurones.
Nicolarakis PJ; Lin YQ; Bennett MR
Br J Pharmacol; 1994 Feb; 111(2):521-4. PubMed ID: 7516256
[TBL] [Abstract][Full Text] [Related]
26. Effects of nitric oxide synthase inhibitors on duodenal alkaline secretion in anesthetized rats.
Takeuchi K; Ohuchi T; Miyake H; Niki S; Okabe S
Eur J Pharmacol; 1993 Jan; 231(1):135-8. PubMed ID: 7680316
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide does not mediate acute glutamate neurotoxicity, nor is it neuroprotective, in rat brain slices.
Garthwaite G; Garthwaite J
Neuropharmacology; 1994 Nov; 33(11):1431-8. PubMed ID: 7532826
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide in retina: relation to excitatory amino acids and excitotoxicity.
Zeevalk GD; Nicklas WJ
Exp Eye Res; 1994 Mar; 58(3):343-50. PubMed ID: 7513649
[TBL] [Abstract][Full Text] [Related]
29. Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats.
Plourde V; Quintero E; Suto G; Coimbra C; Taché Y
Eur J Pharmacol; 1994 Apr; 256(2):125-9. PubMed ID: 7519557
[TBL] [Abstract][Full Text] [Related]
30. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.
Bryant CE; Allcock GH; Warner TD
Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283
[TBL] [Abstract][Full Text] [Related]
31. NG-nitro-L-arginine protects against hypoxia/hypoglycemia-induced decrease in CA1 presynaptic spikes in rat hippocampal slices.
Shibata S; Yamamoto Y; Tanaka T; Watanabe S
Eur J Pharmacol; 1995 Feb; 273(3):223-8. PubMed ID: 7537683
[TBL] [Abstract][Full Text] [Related]
32. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse.
Kitto KF; Haley JE; Wilcox GL
Neurosci Lett; 1992 Dec; 148(1-2):1-5. PubMed ID: 1284437
[TBL] [Abstract][Full Text] [Related]
33. Endogenous nitric oxide inhibits NMDA- and kainate- responses by a negative feedback system in rat hippocampal neurons.
Tanaka T; Saito H; Matsuki N
Brain Res; 1993 Dec; 631(1):72-6. PubMed ID: 7905357
[TBL] [Abstract][Full Text] [Related]
34. Possible role of nitric oxide in the development of L-2-chloropropionic acid-induced cerebellar granule cell necrosis.
Widdowson PS; Gyte A; Simpson MG; Farnworth M; Dunn D; Moore RB; Wyatt I; Lock EA
Br J Pharmacol; 1996 Apr; 117(8):1761-7. PubMed ID: 8732288
[TBL] [Abstract][Full Text] [Related]
35. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats.
Rundfeldt C; Koch R; Richter A; Mevissen M; Gerecke U; Löscher W
Eur J Pharmacol; 1995 Feb; 274(1-3):73-81. PubMed ID: 7539378
[TBL] [Abstract][Full Text] [Related]
36. Roles for nitric oxide as an intra- and interneuronal messenger at NMDA release-regulating receptors: evidence from studies of the NMDA-evoked release of [3H]noradrenaline and D-[3H]aspartate from rat hippocampal slices.
Jones NM; Loiacono RE; Beart PM
J Neurochem; 1995 May; 64(5):2057-63. PubMed ID: 7536805
[TBL] [Abstract][Full Text] [Related]
37. Evidence for nitric oxide synthase inhibitor-sensitive and insensitive hippocampal synaptic potentiation.
Gribkoff VK; Lum-Ragan JT
J Neurophysiol; 1992 Aug; 68(2):639-42. PubMed ID: 1382122
[TBL] [Abstract][Full Text] [Related]
38. Evidence that gonadal steroids modulate nitric oxide efflux in the medial preoptic area: effects of N-methyl-D-aspartate and correlation with luteinizing hormone secretion.
Pu S; Xu B; Kalra SP; Kalra PS
Endocrinology; 1996 May; 137(5):1949-55. PubMed ID: 8612535
[TBL] [Abstract][Full Text] [Related]
39. NMDA-dependent nitric oxide release in the hippocampus in vivo: interactions with noradrenaline.
Luo D; Vincent SR
Neuropharmacology; 1994 Nov; 33(11):1345-50. PubMed ID: 7532817
[TBL] [Abstract][Full Text] [Related]
40. Anxiolytic effect of nitric oxide synthase inhibitors microinjected into the dorsal central grey.
Guimarães FS; de Aguiar JC; Del Bel EA; Ballejo G
Neuroreport; 1994 Oct; 5(15):1929-32. PubMed ID: 7531004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
